• Japanese
  • Korean
  • Chinese
Cover Image

Stem Cell Research Products - Opportunities, Tools, and Technologies

Staying ahead of a hungry and fast moving pack of competitors requires the very best market insights.

So let's get straight to the point.

We're offering you access to a sophisticated market intelligence report for the stem cell research supply market.

Whether you already supply stem cell research products or you wish to expand your product line, you'll know just how essential and lucrative this market is. We know you want to make effective product development decisions, to sell more effectively to scientists, to generate improved revenues and take market share from your competition.

This report shows you how to do just that. Helping you understand the prevailing market conditions and giving you guidance to strategically position and develop stem cell product lines.

So when you choose our industry-leading market report, you'll be gaining a competitive advantage in three core areas.

1. Understanding what your customers are thinking

A key component of this report is a survey of the very people you're creating products for. The data gives you an intimate insight into the minds of over 400 research scientists - both domestic and international - working specifically in the stem cell sector.

This expert market intelligence allows you to more profitably focus your research and development budget. With a deeper understanding of the needs of your customers, intelligent product development is the inevitable result. This means you'll develop more successful products and minimize your unprofitable R&D spending.

And, with access to the latest stem cell product research, you'll be able to take advantage of new opportunities before your competitors are even aware of them.

2. Market to these customers more effectively

Just as you can focus your R&D spending on products with the greatest potential, so too can you ensure your marketing dollars work harder and smarter. With the insights and depth of market data contained in this report you can position your products to maximize revenue:

  • Reduce your marketing spending
  • Improve ROI for marketing dollars spent
  • Increase response rates

By understanding the current and future needs of your customer base you can focus your marketing efforts on the most profitable products, in the most promising research areas and within the most lucrative domestic and international markets.

3. Outmaneuver your competition (that's the nice way to put it)

We're witnessing an explosion in the value of the stem cell market, and that means more and more competitors for you.

As a forward-thinking leader, you're not satisfied with maintaining a piece of this ballooning market - you want to dominate it. Of course, your competitors are no different and they're planning to muscle you out of the game.

So sitting still will leave you behind. Our report allows you to do the opposite: to take decisive action, to innovate and to lead.

So avoid the shrinking revenues and squeezed margins that come from increased competition. Absorb this report and make decisions with confidence.

  • Learn the key strengths of your competitors
  • Intelligently position your products to fill gaps in the market
  • Understand crucial trends to stay ahead of your competition.

Tracking stem cell market trends, so you don't have to

We have quantified and assessed the critical trends in the stem cell marketplace, ensuring all information is up-to-date. This means you're able to focus your product development and marketing activity in exactly the right place to beat your competition. We compile and analyze data from a broad range of sources, including:

  • Stem cell grant funding
  • Stem cell patents
  • Stem cell publications
  • Stem cell product launches
  • New entrants to the market
  • International surveys

Not only do we measure these trends, but we also break the data down by stem cell types.

We are loyal to the data and year on year invest heavily in the best data mining and analysis tools. Couple this with our unrivaled knowledge of the stem cell product marketplace, and this report is a road map to your success.

Why is this report different from others available?

It's quite simple. Our report does not look at the whole stem cell industry as if it was one marketplace, a mistake that every other stem cell report makes. As anyone working with stem cells knows, the stem cell market has two very distinct parts: stem cell therapies (the clinical applications of stem cells for medical purposes) and stem cell research products (the research tools and reagents that are used by scientists).

It's the research products market you are interested in. So this entire report is geared toward helping you achieve success in developing and marketing stem cell research products.

What does this means for your business?

These industry insights will allow you to dramatically increase profits in the stem cell sector. And you'll discover a game-changing focus in your marketing and R&D budgets.

However, a word of warning: the report alone will not change your business. But in the hands of a smart and innovative leader, this exclusive information allows you to capture a larger slice of a highly profitable market. A market that will only continue to grow.

The better the information you have, the better the decisions you'll make. So instead of relying only on past performance indicators and incomplete market data, gain the full picture of the stem cell product market through one insightful and up-to-date source.

A market with a billion dollars “up for grabs”

The growth in research into stem cells has exploded in the past decade. And so the market to supply stem cell research products has grown to meet this huge demand.

  • There are now over one million stem cell researchers in 179 countries worldwide.
  • There were 17 companies when we first started monitoring the stem cell research products market in 2004. This has risen to 102 companies today, a 6-fold increase.
  • The stem cell research products market (excluding stem cell antibodies) was valued at $1.28 billion for the full year 2011 and is projected to increase to $2.10 billion by 2016.
  • The total market for all types of stem cell products - including stem cell research products, stem cell antibodies, and stem cell therapies - was valued at $5.72 billion for the full year 2011.

The potential of stem cell research in modern medicine is truly staggering. And when the answers to some of our most challenging health problems are within reach, you can be sure this market is only going to get bigger and more attractive. This is a rapid growth industry.

Precision Valuations, by Market Segment

The report identifies, defines, and quantifies each market segment within the stem cell product industry, including:

You can't accurately produce market valuations without characterizing each segment of the stem cell product market. Our specialized knowledge of the industry means you get accurate, precise valuations for every segment of the market - including the ones that matter most to your business.

Why choose BioInformant to help you succeed?

We could use a lot of clever marketing to persuade you to buy our report. But we know you're smarter than that. And, we simply believe the quality and value of this report speaks for itself.

But just in case you were in doubt, you may like to know we're the only market intelligence company that has specifically tracked the stem cell product supply market since there was a market. We began tracking the stem cell industry in 2004 and have been consulting on stem cell product strategy since 2006.

We have served nearly all of the leading research supply companies in the industry, including Life Technologies, GE Biosciences, Beckman Coulter, BD Biosciences, Thermo Fischer Scientific, Corning, Sigma Aldrich, Johnson & Johnson, and many more.

We know the stem cell industry inside and out.

It means we understand the current and future product trends more intimately than any other company. When we say we're a global leader in stem cell industry data, you can be sure it's not marketing hype.

Put simply: we stay ahead of our competition, so you can stay ahead of yours.


Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into any mature cell type. Several broad categories of stem cells exist, including:

  • Embryonic stem cells, derived from blastocysts
  • Post-natal stem cells, derived from newborn tissues
  • Adult stem cells, found in adult tissues - including Hematopoietic stem cells, Mesenchymal stem cells, and Neural stem cells
  • Induced pluripotent stem cells, reprogrammed from adult cells
  • Cancer stem cells, which give rise to clonal populations of cells that form tumors or disperse in the body
  • Animal stem cells, derived from non-human sources

Stem cells are still a relatively new discovery, as the first mouse embryonic stem cells were derived from embryos in 1981, but it was not until 1995 that the first successful culturing of embryonic stem cells from non-human primates occurred and not until November 1998 a technique was developed to isolate and grow embryonic stem cells from human blastocysts. In 2006, induced pluripotent stem cells were produced for the first time from mouse cells and in 2007 there were produced from human cells. Furthermore, it was not until 2008 that the first full transplant of a human organ grown from adult stem cells was performed (a section of trachea was successfully transplanted into an adult woman in Spain).

The past 10 years have also witnessed the production of piPSCs, R-NSCs, and VSELs. Together, this evidence suggests that additional types of stem cells will likely be discovered, each representing new opportunities for research product development. Clearly, laboratory research into stem cell derivation, manipulation, and application is rapidly expanding.

To facilitate research resulting from these advances, a large and diverse stem cells products market has emerged. Large companies selling stem cell research products include Life Technologies, BD Biosciences, Thermo Fisher Scientific, and EMD Millipore, as well as over one-hundred other suppliers.

Table of Contents



  • A. Human Embryonic Stem Cells (hESCs)
    • 1. Early, 5-7 days (totipotent)
    • 2. Gonadal Ridge, 6 months (multipotent)
  • B. Fetal Stem Cells (pluripotent)
  • C. Umbilical Cord Stem Cells (multipotent)
    • 1. Cord Blood
    • 2. Cord Matrix (“Wharton's Jelly”)
  • D. Dental Stem Cells (multipotent)
  • E. Adult Stem Cells (multipotent)
    • 1. Hematopoietic Stem Cells
    • 2. Mesenchymal Stem Cells
    • 3. Neural Stem Cells
  • F. Cancer Stem Cells (multipotent)
  • G. Induced Pluripotent Stem Cells (iPSCs)
  • H. Novel (recently discovered and uncharacterized) Stem Cell Types
    • 1. Neural Rosette Cells (R-NSCs)
    • 2. Very Small Embryonic Like (VSEL) Stem Cells


  • A. Regenerative Medicine (Cell-Based Therapies)
    • 1. Diabetes Mellitus
    • 2. Cardiovascular Disease
    • 3. Neurological Disease
    • 4. Autoimmune Disease
    • 5. Hematopoietic Disease and Transplantation Research
    • 6. Orthopedic Repair
    • 7. Cancer Research
    • 8. Birth Defect Research
  • B. Non Cell-Based Applications
    • 1. Assays to Aid Early Stage Discovery
    • 2. Improved Prediction of Human Responses
    • 3. Drug Development with Humanized Mouse Models
    • 4. Genetically-Engineered Stem Cell Lines for Screening
    • 5. Pluripotent Stem Cell Lines for Target Validation and Drug Screening
  • C. Birth Defect Research


  • A. Invitrogen Brand of Life Technologies (previously Invitrogen Corporation)
    • 1. Stem Cell Products
      • a. Isolation and Characterization Products
      • b. Expansion and Differentiation Products
    • 2. Collaborations
      • a. Invitrogen and Cellartis AB
      • b. Invitrogen and Novocell
      • c. Invitrogen and the Buck Institute
  • B. BD Biosciences
    • 1. Stem Cell Products
      • a. Isolation
      • b. Culturing
      • c. Analysis
    • 2. Collaborations: BD Biosciences and Stem Cell Technologies
  • C. Comparison of Stem Cell Publication Rates: Invitrogen versus BD Biosciences


  • A. Primary Antibodies
  • B. Bead-based Cell Separations Systems
  • C. Fluorescent-based Labeling and Detection
  • D. Protein Purification and Analysis Tools
    • 1. Protein Purification
    • 2. Stem Cell Protein Analysis
    • 3. Quantitative Proteomics
  • E. DNA/RNA Based Characterization
    • 1. Tools for DNA- and RNA-based Characterization
    • 2. Stem Cell HLA Typing
    • 3. Stem Cell Nucleic Acid Extraction and Purification, PCR/qRT-PCR Reagents
  • F. Isolation / Characterization Services
    • 1. Stem Cell HLA Typing Services
    • 2. Stem Cell Custom Services
    • 3. Stem Cell Custom Antibodies
  • G. Stem Cell Culture Media and Reagents
  • H. Growth Factors and Cytokines
  • I. Stem Cell Gene Regulation
  • J. In vivo / In vitro Stem Cell Tracking
  • K. Expansion / Differentiation Services
    • 1. Stem Cell Media Services
    • 2. RNAi Services
  • L. Stem Cell Lines


  • A. Definition: Stem Cell Research Products
  • B. Experimental Approach
  • C. Stem Cell Research Products, Market Size (in Millions)
  • D. Stem Cell Antibodies, Market Size (in Millions)
  • E. Stem Cell Therapies, Market Size (in Billions)


  • A. Breakdown of Research Segments by End-user Application
    • 1. Basic Research
    • 2. Applied Research
      • a. Autologous and Allogeneic Cell Therapy
      • b. Toxicology Screening for Drug Discovery and Development
  • B. Breakdown of Stem Cell Research by Cell Type
    • 1. Cord Blood Stem Cells
    • 2. Dental Stem Cells
    • 3. iPSCs
  • C. Breakdown of Stem Cell Research by Species
  • D. Publication Rate Analysis
    • 1. Overview of Stem Cell Publication Rates
    • 2. Comparative Analysis of Stem Cell Publication Trends
  • E. Sources of Stem Cell Funding
    • 1. Federal
    • 2. State
    • 3. Private
  • F. Patent Analysis
  • G. Geographical Analysis: Domestic vs. International Status


  • A. Survey Overview
  • B. Characterization of Market Survey Respondents
    • 1. Geographic Distribution of Respondents
    • 2. Respondent Breakdown by Industry Affiliation
    • 3. Breakdown of Respondents by Duration of Stem Cell Activity
  • C. Survey Findings
    • 1. Breakdown of Stem Cell Research Activity by Cell Type
    • 2. Dominant Stem Cell Markers
    • 3. Market Penetration of Stem Cell Markers by Cell Type
      • a. Human Embryonic Stem Cell (hESCs)
      • b. Mesenchymal Stem Cell (MSCs)
      • c. Neural Stem Cells (NSCs)
      • d. Hematopoietic Stem Cells (HSCs)
  • D. Preferred Providers of Stem Cell Antibodies


  • A. Near-term (1-3yrs): Stem Cells as Tools for Drug Discovery
  • B. Short-term (3-5yrs): Therapies Involving Cord Blood and Adult Stem Cells
  • C. Long-Term (10yrs): Therapies involving hESCs


  • A. Top Research Institutions Performing Stem Cell Research
    • 1. University of Wisconsin, including WARF, WiCell, and the WISC Bank
    • 2. Johns Hopkins University
    • 3. US National Institutes of Health (NIH)
    • 4. California Institute for Regenerative Medicine
  • B. Events of Interest


Show More
Get Notified
Email me when related reports are published